Article
Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit.
Leukemia - 1 May 2020
Cucco Francesco, Barrans Sharon, Sha Chulin, Clipson Alexandra, Crouch Simon, Dobson Rachel, Chen Zi, Thompson Joe Sneath, Care Matthew A, Cummin Thomas, Caddy Josh, Liu Hongxiang, Robinson Anne, Schuh Anna, Fitzgibbon Jude, Painter Daniel, Smith Alexandra, Roman Eve, Tooze Reuben, Burton Catherine, Davies Andrew J, Westhead David R, Johnson Peter W M, Du Ming-Qing
Abstract excerpt
Using a Burkitt lymphoma-like gene expression signature, we recently defined a high-risk molecular high-grade (MHG) group mainly within germinal centre B-cell like diffuse large B-cell lymphomas (GCB-DLBCL), which was enriched for MYC/BCL2 double-hit (MYC/BCL2-DH). The genetic basis underlying MHG-DLBCL and their aggressive clinical behaviour remain unknown. We investigated 697 cases of DLBCL, particularly those...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
